Standard Biotools (LAB) Current Leases (2019 - 2026)

Standard Biotools (LAB) has 8 years of Current Leases data on file, last reported at $5.5 million in Q1 2026.

• On a quarterly basis, Current Leases fell 12.54% year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $5.5 million, a 12.54% decrease from a year earlier, with the FY2025 full-year figure at $5.5 million, up 14.23% from the prior year.
• Current Leases for Q1 2026 stood at $5.5 million, up from $5.5 million in the prior quarter.
• Over the last five years, Current Leases for LAB reached as high as $6.3 million in Q1 2025 and fell as low as $3.2 million in Q1 2022.
• Historically, Current Leases has averaged $4.7 million across 5 years, with a median of $4.8 million in 2024.
• Across the five-year window, Current Leases jumped 54.99% in 2024 and declined 16.48% in 2025, its largest moves.
• Year by year, Current Leases stood at $3.7 million in 2022, then increased by 17.41% to $4.3 million in 2023, then rose by 11.17% to $4.8 million in 2024, then rose by 14.23% to $5.5 million in 2025, then rose by 0.91% to $5.5 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $5.5 million in Q1 2026, $5.5 million in Q4 2025, and $5.1 million in Q3 2025.